Alpha-2 Antiplasmin Market - Forecast(2021 - 2026)

 

Alpha-2 Antiplasmin Market Overview 

Alpha-2 Antiplasmin Market size was valued at $ 267.85M by 2019, and is anticipated to grow at a CAGR of 9.35% during the forecast period 2020-2025. The Alpha-2 Antiplasmin Market growth rate is attributed to the growing cost-containment pressures in major industrialized nations and continued technological advances with radically changing Coagulation testing practice presents a significant opportunity in the growth of the Alpha-2 Antiplasmin market in the forecast period of 2020-2025. The antiplasmin or plasmin inhibitor alpha-2 is a type of glycoprotein that is synthesized by the body's liver, kidneys and other tissues. It is a serine protease inhibitor that belongs to the superfamily of Serpin, which functions as the main serine protease plasmin inhibitor. Fibrinolysis occurs due to plasminogen activator conversion from plasminogen to serine protease plasmin. Alpha 2 antiplasmine deficiency induces a bleeding condition due to a rise in fibrinolysis.

Thus, increasing healthcare industry coupled with growing number of metabolic syndrome and various other cardiovascular diseases has led to increase in the demand for Alpha-2 Antiplasmin, thus driving the global Alpha-2 Antiplasmin market in the near future. In addition to this, the advancement in coagulation testing practices is anticipated to drive the global Alpha-2 Antiplasmin market over the forecast period 2020-2025. However, need for highly sophisticated instruments along with stringent regulations are anticipated to restrain the global Alpha-2 Antiplasmin market in the near future.

Report Coverage

The report: “Alpha-2 Antiplasmin Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Alpha-2 Antiplasmin Market:
By Forms: Plasminogen Binding and Non-plasminogen Binding.
By Diagnostic Technologies: Enzyme Linked Immuno-Sorbent Assay (ELISA), Immunohistochemistry and Flow Cytometry.
By End-Use: Hospitals, Clinics, Diagnostic labs and Private Labs.
By Geography: North America, Europe, Asia-Pacific and RoW.

Key Takeaways

  • North America dominated the Alpha-2 Antiplasmin Market with a share of 36.5% in the year 2019.        
  • The factors such as growing cost-containment pressures in major industrialized nations and continued technological advances with radically changing coagulation testing practice are amongst the major factor projected to impel growth of Alpha-2 Antiplasmin Market.
  • Increasing healthcare industry coupled with growing number of metabolic syndrome and various other cardiovascular diseases are the key factors owing to the growth in the segment during forecast period 2020-2025.

Alpha-2 Antiplasmin Market Segment Analysis - By End-Use 

On the basis of end-use, hospitals segment held the major share of the market in terms of revenue and is poised to grow with a CAGR of 5.75%. The reason behind robust growth is being attributed to the continuing contraction of the hospital system and technological advances is to facilitate decentralization of the Alpha-2 Antiplasmin testing closer to the patient, creating additional opportunities for suppliers. This protein is used by the aforementioned end user in patients with alpha-2 antiplasmin or plasmin inhibitor deficiency, especially in patients who have reported severe internal bleeding episodes following minor trauma and joint bleeding.

Alpha-2 Antiplasmin Market Segment Analysis - By Geography

North America dominated the Alpha-2 Antiplasmin Market with a share of 36.5% in 2019. The application of Alpha-2 Antiplasmin has grown rapidly over the last few years owing to the spike in metabolic syndrome cases. Furthermore, excess levels of Alpha-2 anti-plasmin have been shown to be associated with metabolic syndrome and other cardiovascular diseases, thereby driving the market's growth in the region. Alpha-2 antiplasmin protein deficiency causes atherosclerotic plaque to develop, resulting in multiple heart disorders. About 35 percent of adults in the U.S. suffer from metabolic syndrome, according to the American Heart Association. 

Apart from this, the Europe and Asia-Pacific regions are anticipated to witness increased market traction owing to increased incidence rate of cardiovascular diseases.

Alpha-2 Antiplasmin Market Drivers

Growing Metabolic Syndrome

Presently, significant driving force for the growth of the global Alpha-2 Antiplasmin market over the forecast period 2020-2025 is anticipated to be the growing healthcare industry. Rising numbers of metabolic syndromes and other cardiovascular disorders have contributed to a rise in demand for Alpha-2 Antiplasmin in the near future, thereby driving the global market for Alpha-2 Antiplasmin. In addition to this, the Advancement in coagulation testing practices is anticipated to drive the global Alpha-2 Antiplasmin market over the forecast period. Increasing consumption of computerized instrumentation is also projected to augment the global Alpha-2 Antiplasmin market over the forecast period 2020-2025.

Alpha-2 Antiplasmin Market Challenges

Stringent Regulatory Polices

Market growth is poised to be hampered by high development costs, need of highly sophisticated instruments and stringent regulatory policies, in the above mentioned forecast period 2020-2025. 

Alpha-2 Antiplasmin Industry Outlook

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Alpha-2 Antiplasmin Market. In 2019, Alpha-2 Antiplasmin Market share is fragmented by the top ten players present in the market. Alpha-2 Antiplasmin Market top 10 companies are Abbott Laboratories, Axis-Shield plc., Bio/Data Corporation, Becton Dickinson, Corgenix Medical Corporation, Helena Laboratories, Instrumentation Laboratory, Roche, Sysmex Corporation and Thermo Fisher Scientific and others.

Comments

Post a Comment

Popular posts from this blog

Philippines Air Conditioning Market - Forecast(2021 - 2026)

Image
  The air conditioning market in the Philippines reached $8.45 billion in 20018, growing at a CAGR of 4.55% during 2019-2025. The changing tropical weather coupled with rising heat and humidity in the Philippines is the key driving factor for the air conditioning market. During 2015-19, the average temperature in the Philippines from April to July has increased by 28%. In addition to this, a significant proportion of untapped household has kept the opportunity to open for a low-cost air conditioner in this country. In 2018, 23%-27% of total household in the Philippines was not using any air conditioner. Similarly, the Philippines is likely to witness a revision in Minimum Energy Performance Standards (MEPS) policy, as the same policy has not been revised since 2002. Thus, government and regulatory bodies in the Philippines have started initiating to set up new MEPS policy for air conditioning products to meet emerging emission and energy efficiency requirement. This will be likely...
Read more

Animal Nutrition Market - Forecast(2020 - 2025)

Image
  Animal Nutrition Market Overview: As per the Food and Agriculture Organization of the United Nations, the global population will reach the 9 billion mark by 2050, constructing food challenges. Owing to the depletion of arable land as a result of industrialization, food security is a major objective and livestock products are among the prime means to meet such objectives. Economic development has induced pressure on the livestock sector for more efficient production with limited resources; it also supports the income and food security of almost 1.3 billion people. Thus, animal farming sector is capitalizing upon food security concerns, accounting for nearly 40% of the global agricultural production value. Animal nutrition is a necessity with increasing uptake, for the mandatory affluence of global livestock sector and primarily for the rampant production of protein-enriched commodities such as meat, eggs, and milk to feed the majority of the non-vegetarian population globally...
Read more

Ancient Grains Market - Forecast(2021 - 2026)

Image
  Ancient Grains Market Overview  The Chia ancient grains market , which forms part of the larger ancient grains market, is estimated to surpass $2,560.43m by 2023, growing at a CAGR of 36.60% during the forecast period 2018–2023. The ancient grains market is poised to witness significant growth owing to the increased applications of these grains in the food, cosmetics, pharmaceutical, and medical industries. The Americas region is the largest market for ancient grains as the market is more prevalent in South America and the U.S. Ancient Grains Market Outlook Ancient grains are defined as grains that remain largely unchanged over several hundred years. Ancient grains are gaining popularity among the Americans. They are being used in almost everything – from cereals, salads, breads, and crackers to pizza, quiche, and light snacks. Amaranth and quinoa have received considerable interest because of their gluten-free property. Gluten is found in other grains such as wheat, barley,...
Read more